Pharmafile Logo
Pharmafocus logo
Advanced Search
GSK image

GSK China scandal leads to staff conflict

March 11, 2015
Sales and Marketing China, GSK, GlaxoSmithKline, bribery, chinese, cuts, sacked

Around 135 workers who face being removed from their posts by GlaxoSmithKline due to misconduct centering on bribery scandals in …

News
NHS image

Government pledges ‘new era’ for NHS

March 11, 2015
Research and Development, Sales and Marketing NHS, Simon Stevens, five year, reform, reorganisation, vanguard

The government is investing £200 million to back healthcare professionals to implement their own ideas for improving patient care. The …

News

New details of Innovative Medicines review disclosed

March 11, 2015
Research and Development, Sales and Marketing ABPI, NHS, NICE, PPRS, UK, george freeman, innovative medicines

The government has announced details of a sweeping review into how medicines are accessed in the UK. The Innovative Medicines …

News

NICE approves Roche’s Gazyvaro and Novartis’ Xolair

March 11, 2015
Research and Development, Sales and Marketing Gazyvaro, NICE, Novartis, Roche, Xolair, obinutuzumab, omalizumab

NICE today gave the green light to three new biological drugs, after recommending Roche’s Gazyvaro, GSK’s Arzerra and Novartis’ Xolair …

News
tom_griffiths_virgo

New head of digital for Virgo Health

March 11, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo HEALTH, tom griffiths

UK-based healthcare comms agency Virgo Health has increased its leadership team through the appointment of Tom Griffiths as head of digital.  …

Appointment

HRT pills linked to increase in clots and strokes

March 10, 2015
Research and Development, Sales and Marketing Cochrane, HRT, boardman, hormone replacement therapy

HRT tablets do not offer heart benefits and slightly increase the risk of strokes and blood clots in some women. …

News
Lilly image

German court rules against Lilly in Alimta patent case

March 10, 2015
Manufacturing and Production, Sales and Marketing ACS, Actavis, Alimta, NICE, NSCLC, lilly, lung cancer, pemetrexed

A German court has ruled that Lilly’s patent for its lung cancer drug Alimta would not be infringed by generic …

News
Sovaldi image

$10 generic Solvaldi emerges in Bangladesh

March 10, 2015
Manufacturing and Production, Sales and Marketing Gilead, World Trade Organization, hep C, incepta, sofosbuvir, sofosbuvir), sovaldi

A Bangladeshi pharma company is producing an unlicensed generic version of Gilead’s hepatitis C drug Sovaldi for $10 per pill …

News
Champix image

FDA gives new safety warning on Pfizer’s Champix

March 10, 2015
Manufacturing and Production, Sales and Marketing Champix, Cochrane, FDA, MHRA, Pfizer, varenicline

The FDA has warned that Pfizer’s stop smoking drug Champix is linked with seizures, aggressive behaviour and blackouts. In its …

News
Apple’s senior VP of operations Jeff Williams presented ResearchKit at the watch

Apple highlights ‘ResearchKit’ through watch launch

March 10, 2015
Medical Communications, Sales and Marketing Apple, FDA, digital, health, healthkit, researchkit, wearables

US tech giant Apple has finally launched its digital wearable device along with a ResearchKit platform that allows apps to …

News
Sanofi image

Oncologists say CDF cuts will compromise treatment

March 10, 2015
Sales and Marketing CDF, Jevtana, NHS, NICE, Sanofi, cabazitaxel, doctors.net, m3

Oncologists believe cutting drugs from the Cancer Drugs Fund won’t save the NHS money and will worsen patient outcomes according …

News
robert_castaigne_sanofi

Sanofi names audit committee chairman

March 10, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Robert Castaigne, Sanofi

Sanofi has looked to its own board to fulfil the role of chairman as it names Robert Castaigne chairman of …

Appointment
Targcept image

Targacept and Catalyst sign $100 million deal

March 9, 2015
Research and Development, Sales and Marketing CB 813d, PF-05280602, Targecept, blood disorder, catalyst biosciences

Targacept and Catalyst Biosciences have signed a merger agreement which will see them develop new treatment options for patients with …

News
Saxenda image

Novo Nordisk obesity drug shows added benefits

March 9, 2015
Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight

New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …

News

FDA approves new anti-fungal treatment

March 9, 2015
Sales and Marketing Astellas, Basilea, FDA, US, cresemba, isavuconazonium sulfate, zygomycosis

The FDA has given the OK to Astellas and Basilea for their new treatment in adults with a rare but …

News
Cancer image

Fixing what’s broken: why companies must prioritise innovation in drug development

March 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, The Institute of Cancer Research, innovation, oncology, paul workman

The global system for discovering new cancer drugs is broken. It is failing to turn dramatic scientific advances into enough …

Feature
franklin_berger

ESSA Pharma appoints independent director

March 9, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing essa pharma, franklin berger

US pharma development firm ESSA Pharma has appointed Franklin Berger as an independent director. A resident of New York, Berger’s …

Appointment
Merck image

Merck and NewLink Ebola vaccine trial begins

March 6, 2015
Sales and Marketing Ebola, Merck, Vaccine, WHO, newlink, rVSV-EBOV

Merck and US-based biopharma firm NewLink Genetics’ investigational Ebola vaccine is being used in Phase III trials in West Africa. …

News
Novartis image

Novartis secures first US biosimilar product

March 6, 2015
Research and Development, Sales and Marketing Amgen, Cancer, FDA, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, filgrastim-sndz

Novartis’ generic arm Sandoz has won the race to become the first company to market a biosimilar in the US …

News
Keytruda image

Merck and Eisai partner on cancer therapy trial

March 6, 2015
Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1

Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026